Identification of Potential Therapeutic Drugs for Huntington's Disease using Caenorhabditis elegans

BACKGROUND: The prolonged time course of Huntington's disease (HD) neurodegeneration increases both the time and cost of testing potential therapeutic compounds in mammalian models. An alternative is to initially assess the efficacy of compounds in invertebrate models, reducing time of testing...

Descripción completa

Detalles Bibliográficos
Autores principales: Voisine, Cindy, Varma, Hemant, Walker, Nicola, Bates, Emily A., Stockwell, Brent R., Hart, Anne C.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876812/
https://www.ncbi.nlm.nih.gov/pubmed/17551584
http://dx.doi.org/10.1371/journal.pone.0000504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876812/
https://www.ncbi.nlm.nih.gov/pubmed/17551584
http://dx.doi.org/10.1371/journal.pone.0000504

Ejemplares similares